- Home
- TVRD vs SNFCA Comparison
TVRD vs SNFCA Comparison
Compare TVRD & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- SNFCA
- Stock Information
- Founded
- TVRD 2017
- SNFCA 1965
- Country
- TVRD United States
- SNFCA United States
- Employees
- TVRD N/A
- SNFCA N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- SNFCA Finance: Consumer Services
- Sector
- TVRD Health Care
- SNFCA Finance
- Exchange
- TVRD Nasdaq
- SNFCA Nasdaq
- Market Cap
- TVRD 246.5M
- SNFCA 242.0M
- IPO Year
- TVRD N/A
- SNFCA N/A
- Fundamental
- Price
- TVRD $28.98
- SNFCA $10.03
- Analyst Decision
- TVRD Strong Buy
- SNFCA
- Analyst Count
- TVRD 2
- SNFCA 0
- Target Price
- TVRD $52.00
- SNFCA N/A
- AVG Volume (30 Days)
- TVRD 48.4K
- SNFCA 32.4K
- Earning Date
- TVRD 05-13-2025
- SNFCA 05-15-2025
- Dividend Yield
- TVRD N/A
- SNFCA N/A
- EPS Growth
- TVRD N/A
- SNFCA 11.71
- EPS
- TVRD N/A
- SNFCA 0.98
- Revenue
- TVRD N/A
- SNFCA $336,074,193.00
- Revenue This Year
- TVRD N/A
- SNFCA N/A
- Revenue Next Year
- TVRD N/A
- SNFCA N/A
- P/E Ratio
- TVRD N/A
- SNFCA $10.08
- Revenue Growth
- TVRD N/A
- SNFCA 4.96
- 52 Week Low
- TVRD $8.13
- SNFCA $6.95
- 52 Week High
- TVRD $34.31
- SNFCA $13.59
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- SNFCA 44.18
- Support Level
- TVRD N/A
- SNFCA $9.64
- Resistance Level
- TVRD N/A
- SNFCA $10.28
- Average True Range (ATR)
- TVRD 0.00
- SNFCA 0.48
- MACD
- TVRD 0.00
- SNFCA -0.01
- Stochastic Oscillator
- TVRD 0.00
- SNFCA 16.18
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About SNFCA Security National Financial Corporation
Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.